Home Newsfeeds Macquarie Upgrades New Oriental Education to Outperform

Macquarie Upgrades New Oriental Education to Outperform

Macquarie analyst Linda Huang upgrades New Oriental Education (NYSE:EDU) from Neutral to Outperform.

byBenzinga Newsdesk

July 28, 2022

1 minute read

Macquarie analyst Linda Huang upgrades New Oriental Education (NYSE:EDU) from Neutral to Outperform.

Stephens & Co. Reiterates Equal-Weight on Amedisys, Maintains $103 Price Target

By Benzinga Newsdesk

March 14, 8:13 AM

Stephens & Co. analyst Scott Fidel reiterates Amedisys (NASDAQ:AMED) with a Equal-Weight and maintains $103 price target.

AMED

DA Davidson Maintains Neutral on First Busey, Lowers Price Target to $25

By Benzinga Newsdesk

January 26, 11:21 AM

DA Davidson analyst Jeff Rulis maintains First Busey (NASDAQ:BUSE) with a Neutral and lowers the price target from $27 to $25.

BUSE

Gold Moves Higher; Outlook Therapeutics Shares Plummet

By Lisa Levin

August 30, 12:28 PM

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Wednesday. The Dow traded up 0.14% to 34,900.33 while the NASDAQ rose 0.69% to 14,040.27. The S&P 500, also rose, gaining, 0.44% to 4,517.52.

AMBA

Microsoft’s Latest Security Breach: What’s At Stake For Company Integrity And Trust?

By Franca Quarneti

April 10, 3:02 PM

Microsoft addresses a security lapse exposing crucial internal data. Learn more about the findings and implications for cybersecurity.

MSFT

Macquarie Upgrades New Oriental Education to Outperform

Related Posts

Stephens & Co. Reiterates Equal-Weight on Amedisys, Maintains $103 Price Target

DA Davidson Maintains Neutral on First Busey, Lowers Price Target to $25

Gold Moves Higher; Outlook Therapeutics Shares Plummet

Microsoft’s Latest Security Breach: What’s At Stake For Company Integrity And Trust?